COVID-19 | Disease | Life Science News | WHO
Global tuberculosis progress at risk during COVID-19 pandemic
On Oct. 14, 2020, the World Health Organization (WHO) announced that prior to the COVID-19 pandemic, many countries…
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
Declines in ED visits for TBIs (including concussions) among children from contact sports
On Jul. 9, 2020, the CDC reported that after a decade of increasing rates, contact sportsﾖrelated TBI ED…
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
NIH study showed markers in blood can help identify risk for complications after Brain Injury
On May 27, 2020, the National Institutes of Health (NIH) announced it had found that molecules released into…
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Oxford Immunotec announced successful re-registration of the T-SPOT.TB test in China
On Apr. 21, 2020, University of Oxford announced that it had successfully obtained re-registration of the T-SPOT.TB test…
The CDC reported the pace of tuberculosis decline in the U.S. slowed in recent years
On Mar. 20, 2020, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis (TB) incidence in…
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
GSK licensed tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
On Jan. 27, 2020, GSK announced that it had licensed its M72/AS01E[3] tuberculosis disease (TB) vaccine candidate to…
TB Alliance announced partnership with Hongqi Pharma to commercialize therapy for d Drug-resistant TB in China
On Jan. 17, 2020, the Non-profit drug developer TB Alliance granted Shenyang Hongqi Pharmaceuticals , a subsidiary of…
Penn Medicine researchers received $97 million grant from the NIH to study traumatic brain injuries and neurodegeneration
On Oct. 24, 2019, Penn Medicine researchers received $9.7 million grant from the NIH to study traumatic brain…
Biotechnology | Infectious Disease | Life Science News | NIH | Non-Profit Research | Therapeutics | Vaccine
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
Chembio Diagnostics announced agreement with Perseus Science to advance point-of-care concussion test
On May 7, 2019, Chembio Diagnostics announced an agreement with Perseus Science Group, to advance the development of…
Emory University School of Medicine received a $500,000 grant from CDC to research children’s recovery from mild traumatic brain injury (mTBI)
On Jan. 7, 2019, the Emory University School of Medicine received a $500,000 grant from the Centers for…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
The Tennessee Biotechnology Association was established
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
The Stop TB Partnership was established
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study found no benefit from use of beta-carotene supplements
On Apr. 14, 1994, the Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study found no benefit from the use of…
Biotechnology | CDC | HIV | Life Science News | Therapeutics
A sharp increase of tuberculosis was reported by the CDC, related to HIV infection and AIDS
In 1991, a sharp increase of tuberculosis was reported by the U.S. Centers for Disease Control and Prevention…
The CDC reported a large outbreak of multidrug-resistant tuberculosis
In 1990, the U.S. Centers for Disease Control and Prevention (CDC) reported a large outbreak of of nosocomial…
Bethesda System Conference developed system for standardized Pap smear reporting
In December 1988, the National Cancer Institute (NCI) sponsored a workshop to address the standardization of cervical/vaginal cytopathology…
The CDC reported the first drug-resistant tuberculosis outbreak
In May 1978, the U.S. Centers for Disease Control and Prevention (CDC) reported a patient was first diagnosed…
Biology | CDC | Diagnostics | Infectious Disease | Life Science History | NIH | Plague | Therapeutics | Vaccine
The CDC opened an expanded maximum containment lab (hot lab) for highly dangerous viruses
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) completed construction of a new hot lab…
The Tuberculosis Program transferred from the U.S. Public Health Service to CDC
In 1960, the U.S. Public Health Service (USPHS) TB control and clinical research program was transferred to the…
The Communicable Disease Center National Surveillance Program was developed
In 1953, national incidence reporting began in the U.S., with documented cases and operational data from each reporting…
The city of Seattle created a locked ward for TB sufferers who deny treatment
In 1949, to help stem the spread of tuberculosis, the city of Seattle created a locked ward for…
Dr. Armand Frappier conducted the first studies to validate the tuberculosis vaccine
In 1938, Dr. Armand Frappier, at the Institut de Microbiologie et d’Hygiene de Montreal, conducted the first studies…